PARIS–(BUSINESS WIRE)–Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced outstanding 12-month data for the DynamX™ Coronary Bioadaptor System, the first coronary artery implant that adapts to vessel physiology. Results will be presented live tomorrow at 14:12 CEST on the Main Arena channel of the PCR e-Course as part […]
Other News
Avive Solutions Raises Additional $7m for Revolutionary Cardiac Arrest Response Technology
Avive Solutions raises additional $7M led by Laerdal Million Lives Fund for revolutionary cardiac arrest response technology. (Graphic: Business Wire) June 25, 2020 12:26 PM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Avive Solutions, Inc. (“Avive” or the “Company”) has announced it has raised an additional $7 Million in funding, bringing the total […]
Affluent Medical Announces the Launch of the MINERVA First-In-Human Clinical Study of EPYGON
EPYGON is the first native-like transcatheter mitral valve replacement technology aiming at achieving better clinical outcomes The Austrian Competent Authority has granted authorization to start patient enrollment at Vienna General Hospital (AKH) The EPYGON valve has the potential to become a new paradigm in the treatment of functional mitral regurgitation […]
BioSig Technologies, Inc. Announces $17.5 Million Common Stock Only Registered Direct Offering
Westport, CT, June 24, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 2,187,500 shares of the Company’s common stock, at a purchase price of $8.00 […]
Okami Medical Announces Closing of $7.2M Series D Financing
ALISO VIEJO, Calif., June 24, 2020 /PRNewswire/ — Okami Medical Inc., announced today the close of a Series D financing totaling $7.2 million. The financing was led by U.S. Venture Partners and was joined by members of Okami’s board of directors and medical device industry veterans. The financing provides Okami, the second portfolio company of […]
Windtree Announces Initial European Trial Sites Activated in AEROSURF® Bridging Study and a Collaboration for a Concomitant Independent Cerebral Physiology Study
WARRINGTON, Pa., June 24, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced that all initial European trial sites are active and enrolling or able to enroll patients into […]
BAROSTIM™ NEO Associated with Very High Responder Rates in Women
BeAT-HF Trial Results Presented as Late-Breaking Clinical Science at ESC Heart Failure 2020 Meeting MINNEAPOLIS, June 23, 2020 /PRNewswire/ — CVRx, Inc., a private medical device company, announced new BeAT-HF trial results from late-breaking clinical science presented virtually at the European Society of Cardiology Heart Failure 2020 Scientific Sessions. The BAROSTIM NEO […]
Biomerics Launches Online Store for Medical Balloons
SALT LAKE CITY, June 24, 2020 /PRNewswire/ — Biomerics, LLC, a mid-market medical device contract manufacturer specializing in interventional and radiology markets, launched an online store to sell medical balloons. This new e-Commerce platform will sell a range of off-the-shelf Nylon, PET, and LDPE medical balloons. The fast-turn store enables engineers to […]
preCARDIA, Inc. Receives FDA Breakthrough Device Designation for Novel, Catheter Based Heart Failure Treatment
Pioneering technology is designed to address Acute Decompensated Heart Failure ST. PAUL, Minn., June 23, 2020/PRNewswire/ — preCARDIA, Inc., has announced that the company’s catheter based system for treating volume overload in patients with acutely decompensated heart failure (ADHF) has been designated for the Breakthrough Devices Program by the U.S. […]
Ablacon, Inc. Announces the Formation of Scientific Advisory Board
Scientific advisory board composed of thought leaders in electrophysiology and treatment of atrial fibrillation MENLO PARK, Calif., June 23, 2020 /PRNewswire/ — Ablacon, Inc., an Ajax Health-backed company, announced today the formation of its Scientific Advisory Board (SAB). The SAB will be composed of four internationally recognized thought leaders in the field of electrophysiology […]
Recent
Anaxiom Announces Early Clinical Results from First-in-Human Experience of Novel Minimally Invasive Obesity Device; Advances Toward U.S. Early Feasibility Study
NEW STUDY LINKS GLP-1 MEDICATIONS TO LOWER RISK OF ATRIAL FIBRILLATION, INDEPENDENT OF WEIGHT LOSS
Late-Breaking Data from PRESERVE Trial Evaluates XVIVO’s HOPE Preservation Approach in Heart Transplantation
Popular
- No commented posts yet